Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.106
Neutral
RSI(14)
44.322
Neutral
STOCH(KDJ)(9,3,3)
19.905
Neutral
ATR(14)
0.163
High Vlolatility
CCI(14)
-42.090
Neutral
Williams %R
66.265
Sell
TRIX(12,20)
-0.145
Sell
StochRSI(14)
100.000
Buy
SIGA Technologies Inc
SIGA6.270USD
0.000
Close 12/26, 16:00（ET）Quotes delayed by 15 min
449.00MMarket Cap
6.01P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of SIGA Technologies Inc
Currency: USD Updated: 2025-12-26Key Insights
SIGA Technologies Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 122/158 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
SIGA Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
SIGA Technologies Inc Highlights
StrengthsRisks
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.23% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 138.72M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 72.80%.
Fairly Valued
The company’s latest PE is 6.01, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 35.40M shares, decreasing 12.66% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 3.63K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.00.
Financial Health
Currency: USD Updated: 2025-12-26The current financial score of SIGA Technologies Inc is 6.58, ranking 142/158 in the Pharmaceuticals industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 2.62M, representing a year-over-year decrease of 73.83%, while its net profit experienced a year-over-year decrease of 573.67%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.22
Operational Efficiency
3.86
Growth Potential
5.59
Shareholder Returns
5.24
SIGA Technologies Inc's Company Valuation
Currency: USD Updated: 2025-12-26The current valuation score of SIGA Technologies Inc is 5.26, ranking 150/158 in the Pharmaceuticals industry. Its current P/E ratio is 6.01, which is 134.91% below the recent high of 14.11 and 1358.00% above the recent low of -75.58.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 122/158
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-26No earnings forecast score is currently available for SIGA Technologies Inc. The Pharmaceuticals industry's average is 7.80.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-26The current price momentum score of SIGA Technologies Inc is 7.09, ranking 92/158 in the Pharmaceuticals industry. Currently, the stock price is trading between the resistance level at 6.59 and the support level at 5.90, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
6.258
Buy
MA10
6.304
Sell
MA20
6.243
Buy
MA50
6.861
Sell
MA100
7.784
Sell
MA200
6.880
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-26The current institutional shareholding score of SIGA Technologies Inc is 3.00, ranking 92/158 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 49.44%, representing a quarter-over-quarter decrease of 47.74%. The largest institutional shareholder is The Vanguard, holding a total of 2.62M shares, representing 3.66% of shares outstanding, with 5.18% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
MacAndrews & Forbes Holdings, Inc.
Lewis (John Latane IV)
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
AltraVue Capital, LLC.
American Century Investment Management, Inc.
Citadel Advisors LLC
State Street Investment Management (US)
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-26The current risk assessment score of SIGA Technologies Inc is 5.02, ranking 76/158 in the Pharmaceuticals industry. The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.98
VaR
+5.27%
240-Day Maximum Drawdown
+39.14%
240-Day Volatility
+48.23%
Return
Best Daily Return
60 days
+5.23%
120 days
+17.77%
5 years
+43.35%
Worst Daily Return
60 days
-19.95%
120 days
-19.95%
5 years
-28.30%
Sharpe Ratio
60 days
-2.69
120 days
+0.02
5 years
+0.51
Risk Assessment
Maximum Drawdown
240 days
+39.14%
3 years
+56.39%
5 years
+82.12%
Return-to-Drawdown Ratio
240 days
+0.36
3 years
+0.12
5 years
+0.08
Skewness
240 days
+0.02
3 years
-0.16
5 years
+1.59
Volatility
Realised Volatility
240 days
+48.23%
5 years
+70.60%
Standardised True Range
240 days
+4.40%
5 years
+5.74%
Downside Risk-Adjusted Return
120 days
+3.29%
240 days
+3.29%
Maximum Daily Upside Volatility
60 days
+29.67%
Maximum Daily Downside Volatility
60 days
+46.06%
Liquidity
Average Turnover Rate
60 days
+0.66%
120 days
+0.69%
5 years
--
Turnover Deviation
20 days
-0.15%
60 days
-27.97%
120 days
-24.51%
Peer Comparison
Pharmaceuticals
SIGA Technologies Inc
SIGA
4.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mirum Pharmaceuticals Inc
MIRM
8.78 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Regeneron Pharmaceuticals Inc
REGN
8.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Gilead Sciences Inc
GILD
8.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Collegium Pharmaceutical Inc
COLL
8.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Prestige Consumer Healthcare Inc
PBH
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of SIGA Technologies Inc?
The TradingKey Stock Score provides a comprehensive assessment of SIGA Technologies Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of SIGA Technologies Inc’s performance and outlook.
How do we generate the financial health score of SIGA Technologies Inc?
To generate the financial health score of SIGA Technologies Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects SIGA Technologies Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of SIGA Technologies Inc.
How do we generate the company valuation score of SIGA Technologies Inc?
To generate the company valuation score of SIGA Technologies Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare SIGA Technologies Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of SIGA Technologies Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of SIGA Technologies Inc.
How do we generate the earnings forecast score of SIGA Technologies Inc?
To calculate the earnings forecast score of SIGA Technologies Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on SIGA Technologies Inc’s future.
How do we generate the price momentum score of SIGA Technologies Inc?
When generating the price momentum score for SIGA Technologies Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of SIGA Technologies Inc’s prices. A higher score indicates a more stable short-term price trend for SIGA Technologies Inc.
How do we generate the institutional confidence score of SIGA Technologies Inc?
To generate the institutional confidence score of SIGA Technologies Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about SIGA Technologies Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of SIGA Technologies Inc.
How do we generate the risk management score of SIGA Technologies Inc?
To assess the risk management score of SIGA Technologies Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of SIGA Technologies Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of SIGA Technologies Inc.
